Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 122-130 , March 2006

Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology

  • Alan K. Meeker, M.A., Ph.D.

      Affiliations

    • Corresponding Author InformationTel.: +1-410-502-7880/502-7354; fax: +1-410-502-9817.

References 

  1. DeMarzo AM , Nelson WG , Isaacs WB , et al.   Pathological and molecular aspects of prostate cancer . Lancet . 2003;361:955–964
  2. Shah RB , Mehra R , Chinnaiyan AM , et al.   Androgen-independent prostate cancer is a heterogeneous group of diseases (Lessons from a rapid autopsy program) . Cancer Res . 2004;64:9209–9216
  3. Visakorpi T . The molecular genetics of prostate cancer . Urology . 2003;62(Suppl 5):3–10
  4. Hartwell L . Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells . Cell . 1992;71:543–546
  5. Vogelstein B , Kinzler KW . Cancer genes and the pathways they control . Nat Med . 2004;10:789–799
  6. Weinberg RA . Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis . Cancer Res . 1989;49:3713–3721
  7. Kinzler KW , Vogelstein B . Cancer-susceptibility genes . Gatekeepers and caretakers. Nature . 1997;386:761
  8. Sherr CJ . Principles of tumor suppression . Cell . 2004;116:235–246
  9. Nelson WG , De Marzo AM , Isaacs WB . Prostate cancer . N Engl J Med . 2003;349:366–381
  10. Wolf M , Mousses S , Hautaniemi S , et al.   High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays (Impact of copy number on gene expression) . Neoplasia . 2004;6:240–247
  11. Al-Maghrabi J , Vorobyova L , Chapman W , et al.   p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma (Analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens) . Mod Pathol . 2001;14:1252–1262
  12. Beheshti B , Park PC , Sweet JM , et al.   Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis . Neoplasia . 2001;3:62–69
  13. Cher ML , MacGrogan D , Bookstein R , et al.   Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer . Genes Chromosomes Cancer . 1994;11:153–162
  14. Joos S , Bergerheim US , Pan Y , et al.   Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization . Genes Chromosomes Cancer . 1995;14:267–276
  15. Nupponen NN , Kakkola L , Koivisto P , et al.   Genetic alterations in hormone-refractory recurrent prostate carcinomas . Am J Pathol . 1998;153:141–148
  16. Isaacs WB , Bova GS , Morton RA , et al.   Molecular biology of prostate cancer . Semin Oncol . 1994;21:514–521
  17. Lengauer C , Kinzler KW , Vogelstein B . Genetic instabilities in human cancers . Nature . 1998;396:643–649
  18. Qian J , Jenkins RB , Bostwick DG . Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization . Eur Urol . 1999;35:479–483
  19. Macoska JA , Trybus TM , Sakr WA , et al.   Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer . Cancer Res . 1994;54:3824–3830
  20. Erbersdobler A , Gurses N , Henke RP . Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma . Pathol Res Pract . 1996;192:418–427
  21. Heinen CD , Schmutte C , Fishel R . DNA repair and tumorigenesis (Lessons from hereditary cancer syndromes) . Cancer Biol Ther . 2002;1:477–485
  22. Blackburn EH . Telomeres . Trends Biochem Sci . 1991;16:378–381
  23. Moyzis RK , Buckingham JM , Cram LS , et al.   A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes . Proc Natl Acad Sci USA . 1988;85:6622–6626
  24. Meyne J , Ratliff RL , Moyzis RK . Conservation of the human telomere sequence (TTAGGG) among vertebrates . Proc Natl Acad Sci USA . 1989;86:7049–7053
  25. Saldanha SN , Andrews LG , Tollefsbol TO . Assessment of telomere length and factors that contribute to its stability . Eur J Biochem . 2003;270:389–403
  26. Karlseder J . Telomere repeat binding factors (Keeping the ends in check) . Cancer Lett . 2003;194:189–197
  27. Harley CB , Futcher AB , Greider CW . Telomeres shorten during ageing of human fibroblasts . Nature . 1990;345:458–460
  28. Lindsey J , McGill NI , Lindsey LA , et al.   In vivo loss of telomeric repeats with age in humans . Mutat Res . 1991;256:45–48
  29. Hastie ND , Dempster M , Dunlop MG , et al.   Telomere reduction in human colorectal carcinoma and with ageing . Nature . 1990;346:866–868
  30. Levy MZ , Allsopp RC , Futcher AB , et al.   Telomere end-replication problem and cell aging . J Mol Biol . 1992;225:951–960
  31. Kruk PA , Rampino NJ , Bohr VA . DNA damage and repair in telomeres (Relation to aging) . Proc Natl Acad Sci USA . 1995;92:258–262
  32. von Zglinicki T , Pilger R , Sitte N . Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts . Free Radic Biol Med . 2000;28:64–74
  33. Greider CW , Blackburn EH . Identification of a specific telomere terminal transferase activity in Tetrahymena extracts . Cell . 1985;43:405–413
  34. Reddel RR . Alternative lengthening of telomeres, telomerase, and cancer . Cancer Lett . 2003;194:155–162
  35. McClintock B . The stability of broken ends of chromosomes in Zea mays . Genetics . 1941;26:234–282
  36. Lo AW , Sabatier L , Fouladi B , et al.   DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line . Neoplasia . 2002;4:531–538
  37. Artandi SE , DePinho RA . A critical role for telomeres in suppressing and facilitating carcinogenesis . Curr Opin Genet Dev . 2000;10:39–46
  38. Feldser DM , Hackett JA , Greider CW . Telomere dysfunction and the initiation of genome instability . Nat Rev Cancer . 2003;3: 623–2
  39. Gisselsson D , Pettersson L , Hoglund M , et al.   Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity . Proc Natl Acad Sci USA . 2000;97:5357–5362
  40. Wright WE , Shay JW . Cellular senescence as a tumor-protection mechanism (The essential role of counting) . Curr Opin Genet Dev . 2001;11:98–103
  41. Counter C , Avilion A , LeFeuvre C , et al.   Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity . EMBO J . 1992;11:1921–1929
  42. Artandi SE , Chang S , Lee SL , et al.   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice . Nature . 2000;406:641–645
  43. O’Hagan RC , Chang S , Maser RS , et al.   Telomere dysfunction provokes regional amplification and deletion in cancer genomes . Cancer Cell . 2002;2:149–155
  44. Meeker AK , Gage WR , Hicks JL , et al.   Telomere length assessment in human archival tissues (Combined telomere fluorescence in situ hybridization and immunostaining) . Am J Pathol . 2002;160:1259–1268
  45. Meeker AK , Hicks JL , Platz EA , et al.   Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis . Cancer Res . 2002;62:6405–6409
  46. Vukovic B , Park PC , Al-Maghrabi J , et al.   Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma . Oncogene . 2003;22:1978–1987
  47. Hermeking H . The 14-3-3 cancer connection . Nat Rev Cancer . 2003;3:931–943
  48. Lodygin D , Diebold J , Hermeking H . Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression . Oncogene . 2004;23(56):9034–9041
  49. Fordyce CA , Heaphy CM , Joste NE , et al.   Association between cancer-free survival and telomere DNA content in prostate tumors . J Urol . 2005;173:610–614
  50. Bodnar AG , Ouellette M , Frolkis M , et al.   Extension of life-span by introduction of telomerase into normal human cells . Science . 1998;279:349–352
  51. Vaziri H , Benchimol S . Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span . Curr Biol . 1998;8:279–282
  52. Hahn WC , Counter CM , Lundberg AS , et al.   Creation of human tumour cells with defined genetic elements . Nature . 1999;400:464–468
  53. Elenbaas B , Spirio L , Koerner F , et al.   Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells . Genes Dev . 2001;15:50–65
  54. Kim NW , Piatyszek MA , Prowse KR , et al.   Specific association of human telomerase activity with immortal cells and cancer . Science . 1994;266:2011–2015
  55. Meeker AK , Coffey DS . Telomerase (A promising marker of biological immortality of germ, stem, and cancer cells) . A review. Biochemistry (Mosc) . 1997;62:1323–1331
  56. Shay JW , Bacchetti S . A survey of telomerase activity in human cancer . Eur J Cancer . 1997;33:787–791
  57. Engelhardt M , Albanell J , Drullinsky P , et al.   Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma . Clin Cancer Res . 1997;3:1849–1857
  58. Koeneman KS , Pan CX , Jin JK , et al.   Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN) . J Urol . 1998;160:1533–1539
  59. Kamradt J , Drosse C , Kalkbrenner S , et al.   Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer (A real-time quantification and in situ hybridization study) . Lab Invest . 2003;83:623–633
  60. Kallakury BV , Brien TP , Lowry CV , et al.   Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas . Diagn Mol Pathol . 1997;6:192–198
  61. Sommerfeld HJ , Meeker AK , Piatyszek MA , et al.   Telomerase activity (A prevalent marker of malignant human prostate tissue) . Cancer Res . 1996;56:218–222
  62. Lin Y , Uemura H , Fujinami K , et al.   Telomerase activity in primary prostate cancer . J Urol . 1997;157:1161–1165
  63. Wullich B , Rohde V , Oehlenschlager B , et al.   Focal intratumoral heterogeneity for telomerase activity in human prostate cancer . J Urol . 1999;161:1997–2001
  64. Zhang W , Kapusta LR , Slingerland JM , et al.   Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium . Cancer Res . 1998;58:619–621
  65. Caldarera E , Crooks NH , Muir GH , et al.   An appraisal of telomerase activity in benign prostatic hyperplasia . Prostate . 2000;45:267–270
  66. Wymenga LF , Wisman GB , Veenstra R , et al.   Telomerase activity in needle biopsies from prostate cancer and benign prostates . Eur J Clin Invest . 2000;30:330–335
  67. Takahashi C , Miyagawa I , Kumano S , et al.   Detection of telomerase activity in prostate cancer by needle biopsy . Eur Urol . 1997;32:494–498
  68. Chieco P , Bertaccini A , Giovannini C , et al.   Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens . Eur Urol . 2001;40:666–672
  69. Bertaccini A , Chieco P , Giovannini C , et al.   Biopsying prostate gland (Telomerase evaluation) . Prostate Cancer Prostatic Dis . 1999;2:S6
  70. Scates DK , Muir GH , Venitt S , et al.   Detection of telomerase activity in human prostate (A diagnostic marker for prostatic cancer?) . Br J Urol . 1997;80:263–268
  71. Lin Y , Uemura H , Fujinami K , et al.   Detection of telomerase activity in prostate needle-biopsy samples . Prostate . 1998;36:121–128
  72. Muller M . Determination of the enzyme telomerase in needle biopsies and fine needle aspiration cytology samples of the prostate in the diagnosis of prostate cancer . Prostate Cancer Prostatic Dis . 1999;2:S23
  73. Wang Z , Ramin SA , Tsai C , et al.   Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens . Urol Oncol . 2001;6:57–62
  74. Wang Z , Ramin SA , Tsai C , et al.   Detection of telomerase activity in prostatic fluid specimens . Urol Oncol . 2000;6:4–9
  75. Vicentini C , Gravina GL , Angelucci A , et al.   Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia . J Cancer Res Clin Oncol . 2004;130:217–221
  76. Meid FH , Gygi CM , Leisinger HJ , et al.   The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage . J Urol . 2001;165:1802–1805
  77. Suh CI , Shanafelt T , May DJ , et al.   Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer . Mol Cell Probes . 2000;14:211–217
  78. Liu BC , LaRose I , Weinstein LJ , et al.   Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection . Cancer . 2001;92:1943–1948
  79. Latil A , Vidaud D , Valeri A , et al.   htert expression correlates with MYC over-expression in human prostate cancer . Int J Cancer . 2000;89:172–176
  80. Iczkowski KA , Pantazis CG , McGregor DH , et al.   Telomerase reverse transcriptase subunit immunoreactivity (A marker for high-grade prostate carcinoma) . Cancer . 2002;95:2487–2493
  81. Athanassiadou P , Bantis A , Gonidi M , et al.   Telomerase expression as a marker in prostate cancer (Correlation to clinicopathologic predictors) . J Exp Clin Cancer Res . 2003;22:613–618
  82. Kolquist KA , Ellisen LW , Counter CM , et al.   Expression of TERT in early premalignant lesions and a subset of cells in normal tissues . Nat Genet . 1998;19:182–186
  83. Bettendorf O , Heine B , Kneif S , et al.   Expression-patterns of the RNA component (hTR) and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer . Prostate . 2003;55:99–104
  84. Paradis V , Dargere D , Laurendeau I , et al.   Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue . J Pathol . 1999;189:213–218
  85. de Kok JB , Verhaegh GW , Roelofs RW , et al.   DD3(PCA3), a very sensitive and specific marker to detect prostate tumors . Cancer Res . 2002;62:2695–2698
  86. Snijders PJ , van Duin M , Walboomers JM , et al.   Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions (Strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA) . Cancer Res . 1998;58:3812–3818
  87. Mitchell JR , Cheng J , Collins K . A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end . Mol Cell Biol . 1999;19:567–576
  88. Mitchell JR , Wood E , Collins K . A telomerase component is defective in the human disease dyskeratosis congenita . Nature . 1999;402:551–555
  89. Ford LP , Suh JM , Wright WE , et al.   Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase . Mol Cell Biol . 2000;20:9084–9091
  90. Dragon F , Pogacic V , Filipowicz W . In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs . Mol Cell Biol . 2000;20:3037–3048
  91. LaBranche H , Dupuis S , Ben-David Y , et al.   Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase . Nat Genet . 1998;19:199–202
  92. Holt SE , Aisner DL , Baur J , et al.   Functional requirement of p23 and Hsp90 in telomerase complexes . Genes Dev . 1999;13:817–826
  93. Le S , Sternglanz R , Greider CW . Identification of two RNA-binding proteins associated with human telomerase RNA . Mol Biol Cell . 2000;11:999–1010
  94. Harrington L , McPhail T , Mar V , et al.   A mammalian telomerase-associated protein . Science . 1997;275:973–977
  95. Horikawa I , Barrett JC . Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms . Carcinogenesis . 2003;24:1167–1176
  96. Armbruster BN , Etheridge KT , Broccoli D , et al.   Putative telomere-recruiting domain in the catalytic subunit of human telomerase . Mol Cell Biol . 2003;23:3237–3246
  97. Huard S , Moriarty TJ , Autexier C . The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity . Nucleic Acids Res . 2003;31:4059–4070
  98. Hisatomi H , Ohyashiki K , Ohyashiki JH , et al.   Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene . Neoplasia . 2003;5:193–197
  99. Kugoh H , Shigenami K , Funaki K , et al.   Human chromosome 5 carries a putative telomerase repressor gene . Genes Chromosomes Cancer . 2003;36:37–47
  100. Guilleret I , Yan P , Grange F , et al.   Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity . Int J Cancer . 2002;101:335–341
  101. Guilleret I , Yan P , Guillou L , et al.   The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation . Carcinogenesis . 2002;23:2025–2030
  102. Lin SY , Elledge SJ . Multiple tumor suppressor pathways negatively regulate telomerase . Cell . 2003;113:881–889
  103. Sato K , Qian J , Slezak JM , et al.   Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma . J Natl Cancer Inst . 1999;91:1574–1580
  104. Gil J , Bernard D , Martinez D , et al.   Polycomb CBX7 has a unifying role in cellular lifespan . Nat Cell Biol . 2004;6:67–72
  105. Akalin A , Elmore LW , Forsythe HL , et al.   A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression . Cancer Res . 2001;61:4791–4796
  106. Choi SH , Kang HK , Im EO , et al.   Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids . Int J Oncol . 2000;17:971–976
  107. Hisatake J , Kubota T , Hisatake Y , et al.   5,6-trans-16-ene-vitamin D3 (A new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells) . Cancer Res . 1999;59:4023–4029
  108. Jiang F , Bao J , Li P , et al.   Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase . J Biol Chem . 2004;279:53213–53221
  109. Ikeda N , Uemura H , Ishiguro H , et al.   Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells . Mol Cancer Ther . 2003;2:739–746
  110. Sigala S , Faraoni I , Botticini D , et al.   Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines . Clin Cancer Res . 1999;5(5):1211–1218
  111. Wetterau LA , Francis MJ , Ma L , et al.   Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells . J Clin Endocrinol Metab . 2003;88:3354–3359
  112. Moore MG , Wetterau LA , Francis MJ , et al.   Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells . Int J Cancer . 2003;105:14–19
  113. Meeker AK , Sommerfeld HJ , Coffey DS . Telomerase is activated in the prostate and seminal vesicles of the castrated rat . Endocrinology . 1996;137:5743–5746
  114. Ravindranath N , Ioffe SL , Marshall GR , et al.   Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta . Prostate . 2001;49:79–89
  115. Nanni S , Narducci M , Della Pietra L , et al.   Signaling through estrogen receptors modulates telomerase activity in human prostate cancer . J Clin Invest . 2002;110:219–227
  116. Bouchal J , Kolar Z , Mad’arova J , et al.   The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP . Biochem Pharmacol . 2002;63:1177–1181
  117. Bouchal J , Baumforth KR , Svachova M , et al.   Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines . J Pharm Pharmacol . 2005;57:83–92
  118. Meeker AK . Telomere dynamics and androgen regulation of telomerase enzymatic activity in normal and pathological states of the prostate [PhD thesis] . Baltimore (MD): Johns Hopkins University School of Medicine; 2001; 265
  119. Guo C , Armbruster BN , Price DT , et al.   In vivo regulation of hTERT expression and telomerase activity by androgen . J Urol . 2003;170:615–618
  120. Zhao JQ , Hoare SF , McFarlane R , et al.   Cloning and characterization of human and mouse telomerase RNA gene promoter sequences . Oncogene . 1998;16:1345–1350
  121. Horikawa I , Cable PL , Afshari C , et al.   Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene . Cancer Res . 1999;59:826–830
  122. Cong YS , Wen J , Bacchetti S . The human telomerase catalytic subunit hTERT (Organization of the gene and characterization of the promoter) . Hum Mol Genet . 1999;8:137–142
  123. Takakura M , Kyo S , Kanaya T , et al.   Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells . Cancer Res . 1999;59:551–557
  124. Soda H , Raymond E , Sharma S , et al.   Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro . Prostate . 2000;43:161–168
  125. Thelen P , Wuttke W , Jarry H , et al.   Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells . J Urol . 2004;171:1934–1938
  126. Bosland M . In vivo regulation of hTERT expression and telomerase activity by androgen . J Urol . 2003;170:615–618
  127. Iczkowski KA , Huang W , Mazzucchelli R , et al.   Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT . Cancer . 2004;100:294–299
  128. Silva IS , Morsch DM , Urnauer L , et al.   Androgen-induced cell growth and c-myc expression in human non-transformed epithelial prostatic cells in primary culture . Endocr Res . 2001;27:153–169
  129. Hsing AW , Tsao L , Devesa SS . International trends and patterns of prostate cancer incidence and mortality . Int J Cancer . 2000;85:60–67
  130. De Marzo AM , DeWeese TL , Platz EA , et al.   Pathological and molecular mechanisms of prostate carcinogenesis (implications for diagnosis, detection, prevention, and treatment) . J Cell Biochem . 2004;91:459–477
  131. von Zglinicki T . Oxidative stress shortens telomeres . Trends Biochem Sci . 2002;27:339–344

PII: S1078-1439(05)00262-0

doi: 10.1016/j.urolonc.2005.11.002

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 122-130 , March 2006

Article Tools

* Image Usage & Resolution